Elizabeth Radcliffe

Elizabeth Radcliffe brings over 20 years of experience, with progressive financial leadership roles across the full range of biopharmaceutical R&D, commercial and business operations at both large and small organizations, including contribution to six product launches. She most recently served as Vice President, Finance and Strategy and Treasurer at Arrakis Therapeutics. Prior to Arrakis, Ms. Radcliffe was Vice President, Financial Planning & Analysis at Agios Pharmaceuticals and spent over 10 years at Biogen, culminating in the role of Senior Director, Head of R&D Finance, where she led financial planning and accounting for Biogen’s worldwide R&D and Medical Affairs functions. Her prior leadership roles at Biogen included head of U.S. revenue planning for Biogen’s Multiple Sclerosis and Hemophilia franchises, Head of Portfolio Management, and Director of Corporate FP&A, with earlier experience supporting Business Development and Technical Operations. Earlier in her career, Ms. Radcliffe held consulting positions at The Parthenon Group and Excelon Corporation. She holds a B.S. in chemistry from Yale University, a Master’s degree in organic chemistry from Harvard University, and an M.B.A. from the MIT Sloan School of Management.